- Filed
- Feb 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Feb 2, 2024 | 42.91M sh |
| Shares Diluted | Q3 2024 · Dec 31, 2023 | 43.78M sh |
| Shares Diluted | Q3 2024 · Dec 31, 2023 | 43.76M sh |
| Shares Diluted | Q3 2024 · Dec 31, 2022 | 42.34M sh |
| Shares Diluted | Q3 2024 · Dec 31, 2022 | 42.34M sh |
| Stock Repurchased | Q3 2024 · Dec 31, 2023 | $183K |
| Stock Repurchased | Q3 2024 · Dec 31, 2022 | $884K |
| Capex | Q3 2024 · Dec 31, 2023 | $415K |
| Capex | Q3 2024 · Dec 31, 2022 | $512K |
| Operating Cash Flow | Q3 2024 · Dec 31, 2023 | $6.69M |
| Operating Cash Flow | Q3 2024 · Dec 31, 2022 | −$11.14M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $21.19M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2023 | $16.59M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2022 | $10.22M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $68.57M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $67.57M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $65.81M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $62.91M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | $62.25M |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2022 | $63.87M |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2022 | $70.37M |
| Stockholders Equity restated | Q3 2024 · Mar 31, 2022 | $75.25M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $39.05M |
| Current Liabilities | Q3 2024 · Mar 31, 2023 | $38.04M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $49.03M |
| Total Liabilities | Q3 2024 · Mar 31, 2023 | $48.89M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $70.05M |
| Current Assets | Q3 2024 · Mar 31, 2023 | $62.85M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $117.6M |
| Total Assets | Q3 2024 · Mar 31, 2023 | $111.79M |
| Eps Diluted | Q3 2024 · Dec 31, 2023 | $0.01 |
| Eps Diluted | Q3 2024 · Dec 31, 2023 | $0.07 |
| Eps Diluted | Q3 2024 · Dec 31, 2022 | −$0.05 |
| Eps Diluted | Q3 2024 · Dec 31, 2022 | −$0.34 |
| Eps Basic | Q3 2024 · Dec 31, 2023 | $0.01 |
| Eps Basic | Q3 2024 · Dec 31, 2023 | $0.07 |
| Eps Basic | Q3 2024 · Dec 31, 2022 | −$0.05 |
| Eps Basic | Q3 2024 · Dec 31, 2022 | −$0.34 |
| Rd Expense | Q3 2024 · Dec 31, 2023 | $2.86M |
| Rd Expense | Q3 2024 · Dec 31, 2023 | $7.53M |
| Rd Expense | Q3 2024 · Dec 31, 2022 | $2.05M |
| Rd Expense | Q3 2024 · Dec 31, 2022 | $6.36M |
| Net Income | Q3 2024 · Dec 31, 2023 | $355K |
| Net Income | Q3 2024 · Dec 31, 2023 | $3.03M |
| Net Income | Q3 2024 · Sep 30, 2023 | $551K |
| Net Income | Q3 2024 · Jun 30, 2023 | $2.13M |
| Net Income | Q3 2024 · Dec 31, 2022 | −$2.05M |
| Net Income | Q3 2024 · Dec 31, 2022 | −$14.31M |
| Net Income | Q3 2024 · Sep 30, 2022 | −$7.4M |
| Net Income | Q3 2024 · Jun 30, 2022 | −$4.87M |
| Operating Income | Q3 2024 · Dec 31, 2023 | $394K |
| Operating Income | Q3 2024 · Dec 31, 2023 | $2.82M |
| Operating Income | Q3 2024 · Dec 31, 2022 | −$2.16M |
| Operating Income | Q3 2024 · Dec 31, 2022 | −$14.06M |
| Gross Profit | Q3 2024 · Dec 31, 2023 | $15.55M |
| Gross Profit | Q3 2024 · Dec 31, 2023 | $48.62M |
| Gross Profit | Q3 2024 · Dec 31, 2022 | $11.82M |
| Gross Profit | Q3 2024 · Dec 31, 2022 | $28.53M |
| Cost Of Revenue | Q3 2024 · Dec 31, 2023 | $26.58M |
| Cost Of Revenue | Q3 2024 · Dec 31, 2023 | $80.62M |
| Cost Of Revenue | Q3 2024 · Dec 31, 2022 | $28.87M |
| Cost Of Revenue | Q3 2024 · Dec 31, 2022 | $85.08M |
| Revenue | Q3 2024 · Dec 31, 2023 | $42.13M |
| Revenue | Q3 2024 · Dec 31, 2023 | $129.24M |
| Revenue | Q3 2024 · Dec 31, 2022 | $40.69M |
| Revenue | Q3 2024 · Dec 31, 2022 | $113.61M |